Innovent Biologics (HKG:1801) granted 55,900 share options to five grantees and 488,200 restricted shares to 23 grantees under employees incentive scheme according to a Thursday filing with the Hong Kong Exchange.
The exercise price of the options is HK$38.38 per share and the exercise period of the options will not be longer than 10 years from the date of the grant.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments